SCHEMBL22747952

SCHEMBL22747952

Oc1ccc(/C(F)=C(\F)c2ccc(O)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.53
LMNA P02545 5/20 0.53
HSD17B10 Q99714 4/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
CYP3A4 P08684 3/20 0.53
ALOX15 P16050 3/20 0.53
HIF1A Q16665 3/20 0.53
HPGD P15428 2/20 0.53
CA12 O43570 2/20 0.53
CA3 P07451 2/20 0.53
TYR P14679 2/20 0.53
CA4 P22748 2/20 0.53
CA5A P35218 2/20 0.53
CA9 Q16790 2/20 0.53
CA14 Q9ULX7 2/20 0.53
CA5B Q9Y2D0 2/20 0.53
ALDH1A1 P00352 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11432823 0.88 MAPT (0.47) MAPTLMNAHSD17B10MEN1KMT2A
SCHEMBL27620392 0.83 ESR1 (0.48) MAPTLMNAHSD17B10MEN1KMT2A
SCHEMBL17288654 0.80 MAPT (0.53) MAPTLMNAHSD17B10MEN1KMT2A
SCHEMBL28376070 0.79 ESR1 (0.40) MAPTLMNAHSD17B10MEN1KMT2A
Hydroquinone SCHEMBL3191616 0.78 ALOX15 (0.73) MAPTLMNAHSD17B10MEN1KMT2A
SCHEMBL9225095 0.78 ESR1 (0.56) MAPTLMNAHSD17B10MEN1KMT2A
SCHEMBL27641076 0.75 MAPT (0.60) MAPTLMNAHSD17B10MEN1KMT2A
SCHEMBL21321834 0.73 ESR1 (0.72) MAPTLMNAHSD17B10MEN1KMT2A
Hydroquinone SCHEMBL460669 0.73 ALOX15 (1.00) MAPTLMNAHSD17B10MEN1KMT2A
Hydroquinone SCHEMBL15516 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114207082-B Liquid crystal mixture and liquid crystal display 默克专利股份有限公司 2025-03-18 CN disclosed
EP-3980510-B1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2023-11-08 EP disclosed
EP-3980510-B1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2023-11-08 EP disclosed
US-20220251448-A1 Liquid Crystal Mixture and Liquid Crystal Display MERCK PATENT GMBH (DE) 2022-08-11 US disclosed
EP-3980510-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2022-04-13 EP disclosed
WO-2020245084-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-12-10 WO disclosed
WO-2020245084-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220251448-A1 Liquid Crystal Mixture and Liquid Crystal Display LCT, LSS, NEFM MAPT 486/4885LMNA 1684/4885HSD17B10 344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.